Benzinga's Top Downgrades

Analysts at Jefferies downgraded ONYX Pharmaceuticals

from “buy” to “hold.” The target price for ONYX Pharmaceuticals has been raised from $104 to $132. ONYX's shares closed at $134.40 yesterday. Benchmark downgraded Guidance Software

from “buy” to “sell.” The target price for Guidance Software has been lowered from $9 to $7. Guidance Software's shares closed at $9.53 yesterday. Bank of America downgraded ViroPharma

from “buy” to “neutral.” The target price for ViroPharma is set to $34. ViroPharma's shares closed at $32.00 yesterday. Analysts at Wunderlich downgraded United Stationers

from “buy” to “hold.” The target price for United Stationers has been raised from $39 to $42. United Stationers' shares closed at $42.72 yesterday.